Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H23N7O10 |
Molecular Weight | 497.4161 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=C(N1CCOC(=O)CN(CC(O)=O)CC(=O)OCCN2C(C)=NC=C2[N+]([O-])=O)[N+]([O-])=O
InChI
InChIKey=AWSWJRUMDBPELJ-UHFFFAOYSA-N
InChI=1S/C18H23N7O10/c1-12-19-7-14(24(30)31)22(12)3-5-34-17(28)10-21(9-16(26)27)11-18(29)35-6-4-23-13(2)20-8-15(23)25(32)33/h7-8H,3-6,9-11H2,1-2H3,(H,26,27)
Molecular Formula | C18H23N7O10 |
Molecular Weight | 497.4161 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sodium glycididazole (CMNA), a nitroimidazole compound that has a radiation-enhancing effect. This drug was studied in the treatment of patients with various tumors, such as non-small-cell lung cancer, esophageal carcinoma. CMNA combined with chemoradiotherapy participated in phase II clinical trials in patients with locally recurrent squamous cell esophageal carcinoma. It was shown, that CMNA improved curative effects without increasing adverse reactions, and significantly increase survival rates of the patients. The precise mechanism of action CMNA is not clear but is known that it acts through downregulation of ATM signaling pathway.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP2516 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26586399 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02721576
Sodium Glycididazole (CMNa) 800mg/m2.Three times a week (once every other one day),before radiation therapy, total 5-6 weeks.
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:21:55 GMT 2023
by
admin
on
Sat Dec 16 09:21:55 GMT 2023
|
Record UNII |
B2PT4D6Q3B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9914615
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
DTXSID20432743
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
298688-51-4
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY | |||
|
B2PT4D6Q3B
Created by
admin on Sat Dec 16 09:21:55 GMT 2023 , Edited by admin on Sat Dec 16 09:21:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |